Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders

  • ACS Med Chem Lett. 2025 Feb 11;16(3):377-378. doi: 10.1021/acsmedchemlett.5c00066.
Ram W Sabnis  1 ,  Anika R Sabnis  2
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
  • 2. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.
PMID: 40104807 DOI: 10.1021/acsmedchemlett.5c00066
Abstract

Provided herein are novel compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mental illness or CNS disorders and processes for preparing such compounds.

Products